KPIs & Operating Metrics(New)

Breakdown Of Assets Cardio Metabolic Cardiovascular Revenue Disaggregated Annual Employee Statistics Established Brands Revenue Disaggregated Annual Established Medicines Gross Margin By Segment %Gross Margin By Segment Annual %Gross Profit By Segment Gross Profit By Segment Annual Hematology Hematology Revenue Disaggregated Annual Immunology, Hepatology And Dermatology Immunology Revenue Disaggregated Annual Income Before Income Tax Innovative Medicines Revenue By Region Innovative Medicines Revenue By Region Annual Innovative Medicines Revenue Segregation Innovative Medicines Revenue Segregation Annual Neuroscience Neuroscience Revenue Disaggregated Annual Non Current Assets By Country Annual Non Current Assets By Region Annual Non Ifrs Profitability Non Ifrs Profitability %Non Ifrs Profitability Annual Non Ifrs Profitability Annual %Oncology Operating Income By Segment Operating Margin By Segment %Opex As A % Of Revenue OPEX Segregation Ophthalmology Other Promoted Branda Revenue Disaggregated Annual Pipeline Projects Property, Plant And Equipment Annual Respiratory Revenue By Country Annual Revenue By Country Annual %Revenue By Geography Revenue By Geography %Revenue By Region Revenue By Segment Revenue By Segment %Revenue By Segment % Annual %Revenue By Segment Annual Sandoz Net Sales By Franchise Sandoz Revenue By Region Sandoz Revenue By Region Annual Solid Tumors Revenue Disaggregated Annual

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Novartis Ag (NVS) Respiratory (2016 - 2025)